CYP2S1 and thyroid cancer: In this study, we identify CYP2S1 as a synthetic lethal partner of BRAFV600E in thyroid cancer, and preliminarily reveal the mechanism underlying a synthetic lethal interaction between CYP2S1 and BRAFV600E.